CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 29 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,647 | -40.5% | 10,510 | 0.0% | 0.00% | – |
Q2 2023 | $6,127 | +1.6% | 10,510 | 0.0% | 0.00% | – |
Q1 2023 | $6,031 | -57.0% | 10,510 | -50.0% | 0.00% | – |
Q4 2022 | $14,020 | -6.5% | 21,020 | +100.0% | 0.00% | – |
Q3 2022 | $15,000 | +36.4% | 10,510 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | -65.6% | 10,510 | 0.0% | 0.00% | – |
Q1 2022 | $32,000 | -22.0% | 10,510 | 0.0% | 0.00% | – |
Q4 2021 | $41,000 | -25.5% | 10,510 | 0.0% | 0.00% | – |
Q3 2021 | $55,000 | – | 10,510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |